Anest. intenziv. Med. 2003;14(2):77-81

Subarachnoid Anaesthesia with 0,5% Levobupivacaine (Chirocaine) for Lower Limb in ElectiveOrthopaedic and Trauma SurgeryArticles

I. Herold, J. Nováček, M. Trnovský1, M. Rosický, J. Pečenková, V. Kňourek, L. Piskač, L. Piskačová, J. Sedláček
Anesteziologicko-resuscitační oddělení Klaudiánovy nemocnice, Mladá Boleslav, přednosta MUDr. Ivan Herold, CSc.
1 Ortopedicko-traumatologické oddělení Klaudiánovy nemocnice, Mladá Boleslav, přednosta MUDr. Michal Trnovský

Objective:
New chiral local anaesthetic levobupivacaine has been used until now mostly for epidural anaesthesia/analgesia,plexus and major nerve blocks. There are only a few reports of its use for subarachnoid anaesthesia (SA). The study aimedto evaluate the efficacy and safety of intrathecal administration of 0.5% levobupivacaine, where previously racemicbupivacaine was used almost exclusively.Setting: Department of Anaesthesiology and Intensive Care, Department of Orthopaedic Surgery and Traumatology ofRegional Klaudian's Hospital, Mladá Boleslav.

Material and methods: The authors enrolled 30 patients (ASA I-III, age 15-80, height ≥ ' 2.52 ± 0.56 of the modified Bromage scale. On average, 11.66 ± 1.95 segments were blocked, with upper level of blockadeat Th 9.68 ± 1.83 and lower of S 3.56 ± 0.6. The most frequently anaesthetized segments were L1-S2 (30x), Th12 (29x) andS3 (28x). The most frequent distribution of blocks was: Th10-S4 (5x), Th11-S4 (4x) and Th12-S4 (4x). 2-segmental sensoryblock regression was observed after 138.1 ± 65.49 min,time to motor block regression 235 ± 49.1min.Systolic blood pressurefell compared to basal values after 18., 20., 40. and 60.min (P < 0.05), but the decrease was less than 25%. Similarly, theheart rate fell after 40. and 60. min. (P < 0.05), but the lower level of 50/min was not reached. Quality of anaesthesia,musclerelaxation and comfort of patient evaluated by a 3 point scale were high (2.76 ± 0.4, resp. 2.92 ± 0.3, resp. 2.92 ± 0.24). Duringsurgery, 21 patients (70%) were sedated, mostly with midazolam. Administration of analgesics (mostly pethidin) after thesurgery was required in 21 patients (70%), with first dose required only after 470 ± 162 min from start of anaesthesia. It wasnecessary to insert a bladder catheter for urinary retention in two young men. Other adverse events were not observed.

Conclusion: 15 mg of 0.5% isobaric levobupivacaine was used successfully in a wide range of orthopaedic procedures inlower extremities. Time limitation of estimated length of surgery up to 2,5 hrs corresponded with the observed effectivelength of block and motor regression of block. A high level of satisfaction of anaesthesiologist, surgeon and patient wasachieved. The haemodynamics are not adversely affected.

Keywords: levobupivacaine; subarachnoidal anaesthesia; onset and regression of block; haemodynamic changes; quality of anaesthesia; postoperative analgesia; urinary retention; lower extremity surgery

Published: April 1, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Herold I, Nováček J, Trnovský M, Rosický M, Pečenková J, Kňourek V, et al.. Subarachnoid Anaesthesia with 0,5% Levobupivacaine (Chirocaine) for Lower Limb in ElectiveOrthopaedic and Trauma Surgery. Anest. intenziv. Med. 2003;14(2):77-81.
Download citation




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.